Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Scope of the Report: This report focuses on the Alzheimer?s Disease Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Allergan Eisai Novartis Daiichi Sankyo Merz Pharma Pfizer Johnson & Johnson Lundbeck. Market Segment by Countries, covering United States Canada Mexico Market Segment by Type, covers Donepezil Memantine Rivastigmine Market Segment by Applications, can be divided into Early to Moderate Stages Moderate to Severe Stages There are 15 Chapters to deeply display the North America Alzheimer?s Disease Drug market. Chapter 1, to describe Alzheimer?s Disease Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Alzheimer?s Disease Drug, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Alzheimer?s Disease Drug, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017; Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications; Chapter 10, Alzheimer?s Disease Drug market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022; Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 13, to describe sales channel, distributors, traders, dealers etc. Chapter 14 and 15, to describe Alzheimer?s Disease Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Alzheimer?s Disease Drug Introduction 1.2 Market Analysis by Type 1.2.1 Donepezil 1.2.2 Memantine 1.2.3 Rivastigmine 1.3 Market Analysis by Applications 1.3.1 Early to Moderate Stages 1.3.2 Moderate to Severe Stages 1.4 Market Analysis by Countries 1.4.1 United States Status and Prosp
